4//SEC Filing
Clark Mitchall G. 4
Accession 0001209191-18-032073
CIK 0001604464other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 6:32 PM ET
Size
5.2 KB
Accession
0001209191-18-032073
Insider Transaction Report
Form 4
Clark Mitchall G.
Chief R & QA Officer
Transactions
- Sale
Common Stock
2018-05-18$50.03/sh−25,860$1,293,776→ 107,972 total
Footnotes (2)
- [F1]Transaction pursuant to Rule 10b5-1 Plan adopted January 25, 2018.
- [F2]The price in Column 4 is a weighted average sale price. The prices actually received ranged from $50.00 to $50.10. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001612094
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 6:32 PM ET
- Size
- 5.2 KB